Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neighbourly Pharmacy Inc T.NBLY

Neighbourly Pharmacy Inc. is a Canada-based company that operates a network of community pharmacies. The Company is an owner and operator of retail pharmacies located throughout Canada under banners such as IDA/Guardian, Pharmachoice, Pharmasave and Remedy’s RX. The Company, through its subsidiaries, owns and operates a network of retail pharmacies known as Rubicon Pharmacies (Rubicon or... see more

Bullboard (TSX:NBLY)

View:
Post by stockfyon Oct 13, 2022 8:25am

NBLY and London Drugs start selling DAVIDsTEA (DTEA)

NBLY recently started to sell DAVIDsTEA (DTEA) based on a store-in-store concept. DTEA is a premium tea brand with innovative unique flavors that do not exist in other tea brands including the tea ...more  
Post by retiredcfon Oct 03, 2022 7:59am

Scotia Capital

This new analyst reduced the targets for a multitude of companies. GLTA In a series of research reports released Monday, Scotia Capital analyst George Doumet assumed the firm’s consumer products ...more  
Post by retiredcfon Sep 14, 2022 9:18am

More RBC

Their upside scenario target has been raised to $55.00. GLTA September 13, 2022 Neighbourly Pharmacy Inc. Rx for LT stability - Reiterating constructive LT view despite ...more  
Post by retiredcfon Sep 05, 2022 11:13am

RBC

Current and upside scenario targets are $37.00 and $52.00. GLTA August 30, 2022 Neighbourly Pharmacy Inc. Change of pharmacist: NBLY announces CFO departure, orderly ...more  
Post by incomedreamer11on Aug 26, 2022 9:01am

Scotia comment

Neighbourly Pharmacy Inc. NBLY-T: C$21.00 Target: C$35.00 Old: C$37.00 Rating: Sector Outperform Q1F23: Strong Sales and Gross ...more  
Post by retiredcfon Aug 09, 2022 10:14am

Assessment

Would appreciate your view of their latest quarterly. Am in for long term, 5 years plus, but currently underwater by 15%. Appropriate to increase holding or hold tight?? For the first quarter ...more  
Post by incomedreamer11on Aug 05, 2022 10:07am

IPO price 17 CAD

Will open position around IPO price 17 CAD , no rush to buy now Already did with TIXT and MGTA 
Post by retiredcfon Aug 04, 2022 1:17pm

RBC

Their upside scenario target is $52.00. GLTA August 2, 2022 Outperform TSX: NBLY; CAD 23.21 Price Target CAD 37.00 ↓ 38.00  ...more  
Post by incomedreamer11on Aug 03, 2022 3:18pm

BMO comment

  BMO Capital's Take on Neighbourly Pharmacy's Q1 Results, from 1 hour ago by MT Newswires 1 hour ago by MT Newswires   01:57 PM EDT, 08/03/2022 (MT ...more  
Post by incomedreamer11on Aug 03, 2022 8:41am

Analysts downgrade

fter its first-quarter financial results fell short of expectations, analysts on the Street expect the profitability of Neighbourly Pharmacy Inc. (NBLY-T) to continue to hurt by a higher ...more  
Post by incomedreamer11on Aug 02, 2022 9:13am

TD comments on last result

Neighbourly Pharmacy Inc. (NBLY-T) C$23.21 Q1/23 First Look: Temporarily Higher Costs Pressured Margin Derek J. Lessard Cheryl Zhang, (Associate) Event Neighbourly reported Q1/23 adj. EBITDA of $11 ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities